A missing piece in the puzzle: HIV in mature adults in sub-Saharan Africa

Future Virology

Volumn 6, Issue 6, 2011, Pages 755-767

  Mutevedzi, Portia C ^a,b   Newell, Marie Louise ^a,c  

^a AFRICA HEALTH RESEARCH INSTITUTE   (South Africa)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

ART; diagnosis; elderly; HIV; older adults; prevention

Indexed keywords

ADULT; AFRICA; AGING; ARTHRITIS; CHRONIC KIDNEY DISEASE; COMORBIDITY; DEPRESSION; DIABETES MELLITUS; DISEASE TRANSMISSION; EARLY DIAGNOSIS; HEALTH CARE UTILIZATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV EDUCATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; INFECTION PREVENTION; INFECTION RISK; LIVER DISEASE; MORTALITY; NEOPLASM; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; UNSAFE SEX;

EID: 79958284940     PISSN: 17460794     EISSN: 17460808     Source Type: Journal    
DOI: 10.2217/fvl.11.43     Document Type: Review

References (67)

1. Murray C, Lopez A: Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 349, 1269-1276 (1997). (Pubitemid 27192468)
2. Wallrauch C, Barnighausen T, Newell M-L: HIV infection of concern also in people 50 years and older in rural South Africa. S. Afr. Med. J. 100(12), 821-824 (2010).
3. Schmid GP, Williams BG, Garcia-Calleja JM et al.: The unexplored story of HIV and aging. Bull. World Health Organ. 87(3), 162-162A (2009).
4. Pardi GR, Nunes A, Preto R, Canassa P, Correia D: Profile of adherence to highly active antiretroviral therapy of patients older than 50 years old. J. Acquir. Immune Defic. Syndr. 52(2), 301-302 (2009).
5. Danielson ME, Justice AC: Veterans Aging Cohort Study (VACZ) meeting summary. J. Clin. Epidemiol. 54, S9-S11 (2001). (Pubitemid 34013685)
6. Gebo KA: HIV infection in older people. BMJ 338, B1460 (2009).
7. Negin J, Wariero J, Cumming R, Mutuo P, Pronyk P: High rates of AIDS-related mortality among older adults in rural Kenya. J. Acquir. Immune Defic. Syndr. 55(2), 239-244 (2010).
8. Negin J, Cumming R: HIV infection in older adults in sub-Saharan Africa: extrapolating prevalence from existing data. Bull. World Health Organ. 88, 847-853 (2010).
9. Peltzer K, Phaswana-Mafuya N, Mzolo T, Tabane C, Zuma K: Sexual behaviour, HIV status and HIV risk among older South Africans. Ethno. Med. 4(3), 163-172 (2010).
10. Schartz E, Ogunmefun C: Caring an contributing: the role of older women in rural South African multi-generational households in the HIV/AIDS era. World Dev. 35, 1390-1403 (2007). (Pubitemid 47099456)
11. Mills E, Rammohan A, Awofeso N: Ageing faster with AIDS in Africa. Lancet 377(9772), 1131-1133 (2011).
12. Gebo K: Epidemiology of HIV and response to antiretroviral therapy in the middle aged and elderly. Aging Health 4(6), 615-627 (2008).
13. Herbst AJ, Cooke GS, Barnighausen T, Kanykany A, Tanser F, Newell ML: Adult mortality and antiretroviral treatment roll-out in rural KwaZulu-Natal, South Africa. Bull. World Health Organ. 87(10), 754-762 (2009).
14. Manfredi R, Calza L, Cocchi D, Chiodo F: Antiretroviral treatment and advanced age: epidemiologic, laboratory and clinical features in the elderly. J. Acquir. Immune Defic. Syndr. 33(1), 112-114 (2003). (Pubitemid 36547249)
15. Grabar S, Weiss L, Costagliola D: HIV infection in older patients in the HAART era. J. Antimicrob. Chemother. 57(1), 4-7 (2006). (Pubitemid 43057052)
16. Nguyen N, Holodniy M: HIV infection in the elderly. Clin. Intervent. Aging 3(3), 453-472 (2008).
17. Welz T, Hosegood V, Jaffar S, Batzing-Feigenbaum J, Herbst K, Newell ML: Continued very high prevalence of HIV infection in rural KwaZulu-Natal, South Africa: a population-based longitudinal study. AIDS 21(11), 1467-1472 (2007). (Pubitemid 46988007)
18. Zaba B, Todd J, Biraro S et al.: Diverse age patterns of HIV incidence in Africa. Presented at: XVII International AIDS Conference. Mexico City, Mexico, 3-8 August 2008.
19. Kohli R, Klein R, Schoenbaum E, Anastos K, Minkoff H, Sacks H: Aging and HIV infection. J. Urban Health 83(1), 31-41 (2006).
20. Miles Q, Barnighausen T, Tanser F, Lurie M, Newell M: Age-gaps in sexual partnerships: seeing beyond sugar daddies. AIDS 25(6), 861-863 (2011).
21. Kahn K, Tollman S, Thorogood M et al.: Older adults and the health transition in Agincourt, rural South Africa: new understanding, growing complexity. In: Aging in sub-Saharan Africa: Recommendations for Furthering Research. Cohen B, Menken J (Eds). National Academic Press, Washington, DC, USA, 166-188 (2006).
22. Lau C, Muula A: HIV/AIDS in sub-Saharan Africa. Croat. Med. J. 45(5), 402-414 (2004). (Pubitemid 39208140)
23. Lopez A, Mathers C, Ezzati M, Jamison D, Murray C: Measuring the global burden of disease and risk factors, 1990-2001. In: Global Burden of Disease and Risk Factors. (Eds). Oxford University Press, NY, USA, 1-13 (2006).
24. Christensen K, Doblhammer G, Rau R, Vaupel J: Aging populations: the challenges ahead. Lancet 374, 1196-1208 (2009).
25. Mayosi B, Flisher A, Lalloo U, Sitas F, Tollman S, Bradshwa D: The burden on non-communicable diseases in South Africa. Lancet 374, 934-947 (2009).
26. Rhee MS, Greenblatt DJ: Pharmacologic consideration for the use of antiretroviral agents in the elderly. J. Clin. Pharmacol. 48(10), 1212-1225 (2008).
27. Andrew C, David AC: Adverse effects of retroviral therapy. Lancet 356, 1423-1430 (2000).
28. Kyobutung C, Egondi T, Ezeh A: The health and wellbeing of older people in Nairobis slums. Glob. Health Action S2, 45-53 (2010).
29. Gebo K: HIV and aging: implications for patient management. Drugs Aging 23(11), 897-913 (2006). (Pubitemid 44810777)
30. Justice AC, Landefeld CS, Asch SM, Gifford AL, Whalen CC, Covinsky KE: Justification for a new cohort study of people aging with and without HIV infection. J. Clin. Epidemiol. 54, S3-S8 (2001). (Pubitemid 34019140)
31. Cuzin L, Delpierre C, Gerard S, Massip P, Marchou B: Immunologic and clinical responses to highly active antiretroviral therapy in patients with HIV infection aged >50 years. Clin. Infect. Dis. 45(5), 654-657 (2007). (Pubitemid 47328650)
32. Fabian J, Naicker S: HIV and kidney disease in sub-Saharan Africa. Nat. Rev. Nephrol. 5(10), 591-598 (2009).
33. Sabin CA, Smith CJ, Delpech V et al.: The associations between age and the development of laboratory abnormalities and treatment discontinuation for reasons other than virological failure in the first year of highly active antiretroviral therapy. HIV Med. 10(1), 35-43 (2009).
34. Brinkhof MW, Dabis F, Myer L et al.: Early loss of HIV-infected patients on potent antiretroviral therapy programs in lower-income countries. Bull. World Health Organ. 86(7), 559-567 (2008). (Pubitemid 351931216)
35. Etard JF, Ndiaye I, Thierry-Mieg M et al.: Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study. AIDS 20(8), 1181-1189 (2006). (Pubitemid 43786107)
36. Babiker AG, Peto T, Porter K, Walker AS, Darbyshire JH: Age as a determinant of survival in HIV infection. J. Clin. Epidemiol. 54(Suppl. 1), S16-S21 (2001). (Pubitemid 34013687)
37. Glynn JR, Sonnenberg P, Nelson G et al.: Survival from HIV-1 seroconversion in Southern Africa: a retrospective cohort study in nearly 2000 gold-miners over 10 years of follow-up. AIDS 21(5), 625-632 (2007).
38. Wandel S, Egger M, Rangsin R et al.: Duration from seroconversion to eligibility for antiretroviral therapy and from ART eligibility to death in adult HIV-infected patients from low and middle-income countries: collaborative analysis of prospective studies. Sex. Transm. Infect. 84(Suppl. 1), I31-I36 (2008).
39. Todd J, Glynn J, Marston M et al.: Time from HIV seroconversion to death: a collaborative analysis of eight studies in six low and middle-income countries before highly active antiretroviral therapy. AIDS 21, S55-S63 (2007). (Pubitemid 350158889)
40. Tumbarello M, Rabagliati R, De Gaetano K, Bertagnolio S, Tamburrini E, Cauda R: Older HIV-positive patients in the era of highly active antiretroviral therapy: changing of a scenario. AIDS 17(1), 128-131 (2003). (Pubitemid 36106310)
41. Lawn SD, Little F, Bekker LG et al.: Changing mortality risk associated with CD4 cell response to antiretroviral therapy in South Africa. AIDS 23(3), 335-342 (2009).
42. Toure S, Kouadio B, Seyler C et al.: Rapid scaling-up of antiretroviral therapy in 10,000 adults in Cote dIvoire: 2-year outcomes and determinants. AIDS 22(7), 873-882 (2008). (Pubitemid 351563837)
43. Tuboi SH, Pacheco AG, Harrison LH et al.: Mortality associated with discordant responses to antiretroviral therapy in resource-constrained settings. J. Acquir. Immune Defic. Syndr. 53(1), 70-77 (2010).
44. Brinkhof MW, Boulle A, Weigel R et al.: Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality. PLoS Med. 6(4), E1000066 (2009).
45. Stringer JS, Zulu I, Levy J et al.: Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA 296(7), 782-793 (2006). (Pubitemid 44223102)
46. The Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Study Group: Response to combination antiretroviral therapy: variation by age. AIDS 22(12), 1463-1473 (2008).
47. Fairall LR, Bachmann MO, Louwagie GM et al.: Effectiveness of antiretroviral treatment in a South African program: a cohort study. Arch. Intern. Med. 168(1), 86-93 (2008).
48. Brinkhof MW, Pujades-Rodriguez M, Egger M: Mortality of patients lost to follow-up in antiretroviral treatment programs in resource-limited settings: systematic review and meta-analysis. PLoS One 4(6), E5790 (2009).
49. Macpherson P, Moshabela M, Martinson N, Pronyk P: Mortality and loss to follow-up among HAART initiators in rural South Africa. Trans. R. Soc. Trop. Med. Hyg. 103(6), 588-593 (2009).
50. Negin J, Wariero J, Cumming R, Mutuo P, Pronyk P: High rates of AIDS-related mortality among older adults in rural Kenya. J. Acquir. Immune Defic. Syndr. 55, 239-244 (2010).
51. The Antiretroviral Therapy Cohort Collaboration: Causes of death in HIV-1- infected patients treated with antiretroviral therapy. Clin. Infect. Dis. 50, 1387-1396 (2010).
52. De Wit S, Sabin C, Weber R et al.: Incidence and risk factors for new-onset diabetes in HIV-infected patients. Diabetes Care 31, 1224-1229 (2008).
53. Dunbar-Jacob J, Mortimer-Stephens MK: Treatment adherence in chronic disease. J. Clin. Epidemiol. 54, S57-S60 (2001). (Pubitemid 34013691)
54. Lessells R, Mutevedzi P, Cooke G, Newell M: Retention in HIV care for individuals not yet eligible for antiretroviral therapy: rural KwaZulu Natal, South Africa. J. Acquir Immune Defic. Syndr. 56(3), E79-E86 (2011).
55. Kinsella K, Ferreira M: International Brief - Aging trends: South Africa (1997) www.census.gov/ipc/prod/ib-9702.pdf (Accessed January 2011)
56. Statistics South Africa: Mid-year population estimates, South Africa 2006 www.statssa.gov.za/publications/ statsdownload.asp?PPN=P0302&SCH=3713 (Accessed October 2010)
57. Statistics South Africa: Statistical release. Mid-year population estimates 2010 www.statssa.gov.za/publications/ statsdownload.asp?PPN= P0302&SCH=4696 (Accessed October 2010)
58. Helpage International: UNGASS indicators: where are the over 50s (June 2008) www.globalaging.org/health/world/2008/ UNGASSbriefing.pdf (Accessed January 2011)
59. UNAIDS: Report on the Global AIDS Epidemic (2010) www.unaids.org/en/ media/unaids/ contentassets/documents/ unaidspublication/2010/20101123- globalreport-en.pdf (Accessed January 2011)
60. WHO: Impact of AIDS on older people in Africa: Zimbabwe case study (2002) www.who.int/ageing/projects/hiv/zwe-study/ en/index.html (Accessed February 2011)
61. Report on the global AIDS epidemic http://data.unaids.org/pub/ GlobalReport/2008/JC1511-GR08- ExecutiveSummary-en.pdf (Accessed October 2010)
62. Shisana O, Rehle T, Simbayi LC et al.: South African national HIV prevalence, incidence, behaviour and communication survey 2008: a turning tide among teenagers? (2009) www.mrc.ac.za/pressreleases/2009/sanat.pdf (Accessed December 2010)
63. UNAIDS: Getting to zero: 2011-2015 strategy Joint United Nations Programme on HIV/AIDS (2010) www.unaids.org/en/media/unaids/ contentassets/documents/ unaidspublication/2010/JC2034-UNAIDS- Strategy-en.pdf (Accessed February 2010)
64. National Health Insurance Note 2. Econex Trade, Competition and Applied Economics (2009) www.mediclinic.co.za/about/Documents/ ECONEX%20NHI%20note%202. pdf (Accessed January 2010)
65. National Institute of Aging, NIH: Why population aging matters: a global perspective (2007) www.nia.nih.gov/NR/rdonlyres/9E91407E-CFE8-4903-9875- D5AA75BD1D50/0/ WPAM.pdf (Accessed October 2010).
66. WHO: Scaling up of antiretroviral therapy in resource limited settings: treatment guidelines for a public health approach (2004) www.who.int/hiv/pub/ prev-care/en/ arvrevision2003en.pdf (Accessed January 2011)
67. Collaborative Group on Aids Incubation and HIV Survival: Age at time of seroconversion reported to be key prognostic factor in era before HAART in newly published study www.natap.org/2000/june/age-at- time060500.htm (Accessed May 2010)